The role of depression in the primary prevention of cardiovascular disease
Authors: Hans G Stampfer, Dana A Hince and Simon B Dimmitt
Published online: 15 April 2013
To the Editor: We would like to add a cautionary note to O’Neil’s support for the inclusion of “depression and other psychosocial factors” in the updated National Vascular Disease Prevention Alliance guidelines for assessing cardiovascular disease (CVD) risk. Her statement “it is now clear that depression is also an important risk factor for CVD” is premature.1 Different authors have challenged the suggested relationship and, given divergent findings and opinions, it is misleading to claim that the matter is now “clear”.2-5 We do not deny a possible link between depression and coronary heart disease (CHD) but suggest that the extent and nature of the relationship has yet to be clarified. Premature acceptance and promotion of the idea that depression is a risk factor for CHD might contribute to overdiagnosis and overtreatment of depression as well as undue worry about the risk of CHD by individuals diagnosed with depression.
Competing interests
References
- O’Neil AE. The role of depression in the primary prevention of cardiovascular disease. Med J Aust 2012; 197: 444-445. 0_BABCCBJB
- Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 2006; 27: 2763-2774. 0_i1142861
- Kuper H, Nicholson A, Kivimaki M, et al. Evaluating the causal relevance of diverse risk markers: horizontal systematic review. BMJ 2009; 339: b4265. 0_pgfId-2733842
- Wulsin LR. Is depression a major risk factor for coronary disease? A systematic review of the epidemiologic evidence. Harv Rev Psychiatry 2004; 12: 79-93. 0_pgfId-2733849
- Stampfer HG, Hince DA, Dimmitt SB. Depression as a risk factor for coronary heart disease – how strong is the evidence? O J Psych 2012; 2: 284-291. 0_pgfId-2737516
Fatty Liver Disease in Australia: A Narrative Review on the Epidemiology, Natural History, Prognostication and Management in People With Metabolic Dysfunction
Karl Vaz, Daniel Clayton-Chubb, William W. Kemp, Stuart K. Roberts, Ammar Majeed
Sex Differences in Management and Outcomes of People With ST-Elevation Myocardial Infarction, New South Wales, 2011–2020: A Retrospective Cohort Study
Adam C. Livori, Jedidiah I. Morton, Dianna J. Magliano, Jonathan E. Shaw
Rethinking Rheumatic Fever Diagnosis: Progress, Pitfalls and the Path Towards a Definitive Test
Anna P. Ralph, Rachel Webb, Tom Parks, Nicole J. Moreland, Asha C. Bowen, Benjamin Jones, Emma Ndagire, Andrea Z. Beaton
Sex Differences in Management and Outcomes of People With ST-Elevation Myocardial Infarction, New South Wales, 2011–2020: A Retrospective Cohort Study
Samia Kazi, Simone Marschner, Clara K. Chow
Distribution of Cardiovascular Disease Risk Based on the Updated 2023 Guideline-Recommended Australian Cardiovascular Disease Risk Algorithm and Comparison With the 2012 Algorithm: An Observational Study
Nina Lazarevic, Meghana Bhat, Grace Joshy, Danielle C. Butler, Mark Woodward, Anushka Patel, Rod T. Jackson, Garry Jennings, Rosemary Wyber, Ellie Paige, Emily Banks
They Brought the Hospital to Me
Hugh N. Burrill